Important Announcement
PubHTML5 Scheduled Server Maintenance on (GMT) Sunday, June 26th, 2:00 am - 8:00 am.
PubHTML5 site will be inoperative during the times indicated!

sunny Fang Download
  • 0
  • 0
DS-8201 (Enhertu) A Potential ADC Drug Targeting HER2
Enhertu (fam-Trastuzumab deruxtecan-nxki) is a HER2-targeting ADC drug jointly developed by AstraZeneca and Daiichi Sankyo, also known as DS-8201 or T-DXd.

Like this book? You can publish your book online for free in a few minutes!

Create your own flipbook
View Text Version Likes : 0
Category : All Report
  • Follow

  • Upload

  • 0

  • Embed

  • Share

DS-8201 (Enhertu) A Potential ADC Drug Targeting HER2